Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by First, M. R.
Right arrow Articles by Tejani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by First, M. R.
Right arrow Articles by Tejani, A.

Journal of the American Society of Nephrology, Vol 4, S30-S36, Copyright © 1994 by American Society of Nephrology

REVIEWS

Hypertension after renal transplantation

MR First, JF Neylan, LL Rocher and A Tejani
Division of Nephrology and Hypertension, University of Cincinnati Medical Center, OH 45267-0585.

Hypertension is a frequent complication after organ transplantation in both children and adults and is a significant risk factor for the development of cardiovascular disease and graft dysfunction. There are multiple mechanisms responsible for the development of posttransplant hypertension. In the precyclosporine era, chronic rejection was the most common cause. The introduction of cyclosporine A has increased the prevalence of hypertension in solid organ transplant recipients. Cyclosporine increases renal vascular resistance by causing vasoconstriction of the afferent arteriole. From a pathophysiologic point of view, a calcium channel blocker should be used as the initial therapy in patients with cyclosporine-associated hypertension. Hypertension needs to be treated aggressively in all transplant recipients in an attempt to minimize allograft and cardiovascular damage.


This article has been cited by other articles:


Home page
 CJASNHome page
J. S. Gill
Cardiovascular Disease in Transplant Recipients: Current and Future Treatment Strategies
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(Supplement_2): S29 - S37.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. Hjelmesath, A. Hartmann, K. Midtvedt, S. Aakhus, J. Stenstrom, L. Morkrid, T. Egeland, H. Tordarson, and P. Fauchald
Metabolic cardiovascular syndrome after renal transplantation
Nephrol. Dial. Transplant., May 1, 2001; 16(5): 1047 - 1052.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
J. BEIGE, S. ENGELI, J. RINGEL, G. OFFERMANN, A. DISTLER, and A. M. SHARMA
Donor G Protein {beta}3 Subunit 825TT Genotype Is Associated with Reduced Kidney Allograft Survival
J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1717 - 1721.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
J. M. SOROF, E. K. SULLIVAN, A. TEJANI, and R. J. PORTMAN
Antihypertensive Medication and Renal Allograft Failure: A NorthAmerican Pediatric Renal Transplant Cooperative Study Report
J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1324 - 1330.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
P. F. HALLORAN, A. MELK, and C. BARTH
Rethinking Chronic Allograft Nephropathy: The Concept of AcceleratedSenescence
J. Am. Soc. Nephrol., January 1, 1999; 10(1): 167 - 181.
[Full Text]

Home page
 Mol. Pharmacol.Home page
V. Boss, X. Wang, L. F. Koppelman, K. Xu, and T. J. Murphy
Histamine Induces Nuclear Factor of Activated T Cell-Mediated Transcription and Cyclosporin A-Sensitive Interleukin-8 mRNA Expression in Human Umbilical Vein Endothelial Cells
Mol. Pharmacol., August 1, 1998; 54(2): 264 - 272.
[Abstract] [Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673